NIH Awards Cerebral Amyloid Angiopathy Grant to Amydis Diagnostics


Amydis Diagnostics, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related diseases, announced today that they received a Phase 1 SBIR grant award from the National Institute on Aging of the National Institutes of Health . The grant award for more than $530,000 will fund research and development efforts for novel ophthalmic diagnostic probes for Cerebral Amyloid Angiopathy , an age-associated disease in which proteins called amyloid build up on the walls of the arteries in the brain increasing the risk for stroke caused by bleeding , and dementia .



from Biotech News